Neil Kapp

COO and Co-founder @Kensana

Canada, IL

Kensana Health is a Global Biotech company focused on phyto pharmaceutical technologies with particular focus on wound and pain therapies. Kensana’ s unique approach has proven itself in a clinical setting providing positive therapeutic outcomes for patients who had exhausted all traditional treatments. Kensana’ s Intellectual Property has spurred a paradigm shift in wound care.Dealing with the worst of the worst “incurable wounds” we have an 80% complete wound closure with a median 34 days treatment, conducted on chronic wounds.(Maida et al, 2021) Stimulates underlying pathophysiological processes Decreases pain of wound dressing change Reduced opioid use Easy to apply no specialized nurses required This paradigm shift has lead us to the precipice of beginning Phase 3 clinical trials utilizing our Intellectual Property. Kensana is lead by a seasoned group of entrepreneurial executives dedicated to our path of commercializing and executing on our own technologies as well as those developed by our other partners. We are joint ventured with the Martin Bauer Group and passionate about developing plant based medicines and therapeutics. Although we are pursuing a number of treatments for various indications our primary focus is on chronic wound treatment utilizing a robust portfolio of patents and Intellectual Property.